Eli Lilly’s senior vice president and chief financial officer Josh Smiley announced plans for the Indianapolis-based pharmaceutical company to spend from $1 billion to $5 billion each quarter during 2020 to bolster the drug manufacturer’s product pipeline.
Novo Nordisk’s Ozempic (semaglutide) won approval from the U.S. Food and Drug Administration to reduce the risk of major adverse cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease.
The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) generated an evenly split vote on whether to recommend approval of Durect Corporation’s Posimir.
Leading topics of the 2020 J.P. Morgan Healthcare Conference included a general lack of big deals, defining digital health, and biopharma’s diversity problem.
Novo Nordisk’s new diabetes pill Rybelsus will be covered by Express Scripts Holding Co., one of the largest U.S. pharmacy benefit managers, the Danish drugmaker said on Friday.
Some 170 people who spent time in Yosemite National Park in recent weeks have suffered from a gastrointestinal ailment “consistent with norovirus” and two have been diagnosed with the illness, park officials said.